{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:52:37Z","timestamp":1789213957167,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Biochemical Sciences"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.tibs.2006.06.009","type":"journal-article","created":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T10:02:05Z","timestamp":1152612125000},"page":"533-540","source":"Crossref","is-referenced-by-count":123,"title":["Huntington's disease: seeing the pathogenic process through a genetic lens"],"prefix":"10.1016","volume":"31","author":[{"given":"James F.","family":"Gusella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcy E.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibs.2006.06.009_bib1","first-page":"1","volume":"3","year":"2000"},{"key":"10.1016\/j.tibs.2006.06.009_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajmg.a.20190","article-title":"Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease","volume":"119","author":"Djousse","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.tibs.2006.06.009_bib3","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibs.2006.06.009_bib4","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","article-title":"The association of CAG repeat length with clinical progression in Huntington disease","volume":"66","author":"Rosenblatt","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tibs.2006.06.009_bib5","first-page":"615","article-title":"Huntington's Disease","volume":"Vol. LXI","author":"Gusella","year":"1996"},{"key":"10.1016\/j.tibs.2006.06.009_bib6","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/brain\/awg077","article-title":"Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course","volume":"126","author":"Squitieri","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.tibs.2006.06.009_bib7","first-page":"615","article-title":"Homozygote for Huntington disease","volume":"45","author":"Myers","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tibs.2006.06.009_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/326194a0","article-title":"Homozygotes for Huntington's disease","volume":"326","author":"Wexler","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.tibs.2006.06.009_bib9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"issue":"Suppl","key":"10.1016\/j.tibs.2006.06.009_bib10","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.tibs.2006.06.009_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2005.03348.x","article-title":"Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers","volume":"95","author":"Hoffner","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tibs.2006.06.009_bib12","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","article-title":"Huntingtin aggregation and toxicity in Huntington's disease","volume":"361","author":"Bates","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tibs.2006.06.009_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrm1742","article-title":"Opinion: what is the role of protein aggregation in neurodegeneration? Nat","volume":"6","author":"Ross","year":"2005","journal-title":"Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tibs.2006.06.009_bib14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tibs.2006.06.009_bib15","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions","volume":"102","author":"Slow","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibs.2006.06.009_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.nbd.2005.05.017","article-title":"Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment","volume":"20","author":"Zala","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tibs.2006.06.009_bib17","doi-asserted-by":"crossref","first-page":"17014","DOI":"10.1073\/pnas.252523899","article-title":"Mutational analysis of the structural organization of polyglutamine aggregates","volume":"99","author":"Thakur","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibs.2006.06.009_bib18","doi-asserted-by":"crossref","first-page":"15400","DOI":"10.1073\/pnas.0501651102","article-title":"polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction","volume":"102","author":"Bhattacharyya","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibs.2006.06.009_bib19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jmb.2005.10.053","article-title":"Oligoproline effects on polyglutamine conformation and aggregation","volume":"355","author":"Bhattacharyya","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tibs.2006.06.009_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/hmg\/ddi071","article-title":"A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure","volume":"14","author":"Poirier","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tibs.2006.06.009_bib21","article-title":"Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: implications for pathogenesis","author":"Cong","year":"2005","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.tibs.2006.06.009_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.tibs.2006.06.009_bib23","doi-asserted-by":"crossref","first-page":"50514","DOI":"10.1074\/jbc.M309348200","article-title":"Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells","volume":"278","author":"Gines","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibs.2006.06.009_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1051\/jbio:2005026","article-title":"Huntington's disease: intracellular signaling pathways and neuronal death","volume":"199","author":"Humbert","year":"2005","journal-title":"J. Soc. Biol."},{"key":"10.1016\/j.tibs.2006.06.009_bib25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","article-title":"Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease","volume":"93","author":"Brustovetsky","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tibs.2006.06.009_bib26","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","article-title":"Body weight is modulated by levels of full-length huntingtin","volume":"15","author":"Van Raamsdonk","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tibs.2006.06.009_bib27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-4159.2005.03605.x","article-title":"Wild-type huntingtin protects neurons from excitotoxicity","volume":"96","author":"Leavitt","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tibs.2006.06.009_bib28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.nbd.2005.08.007","article-title":"Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models","volume":"21","author":"Graham","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tibs.2006.06.009_bib29","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","article-title":"Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tibs.2006.06.009_bib30","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tibs.2006.06.009_bib31","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tibs.2006.06.009_bib32","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1152\/jn.00308.2004","article-title":"Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease","volume":"92","author":"Li","year":"2004","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tibs.2006.06.009_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2005.07.014","article-title":"Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin","volume":"21","author":"Tanaka","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tibs.2006.06.009_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/NMM:4:1-2:7","article-title":"Huntington's disease","volume":"4","author":"MacDonald","year":"2003","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.tibs.2006.06.009_bib35","first-page":"21","article-title":"Brain imaging and cognitive dysfunctions in Huntington's disease","volume":"31","author":"Montoya","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.tibs.2006.06.009_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.20684","article-title":"Preclinical Huntington's disease: compensatory brain responses during learning","volume":"59","author":"Feigin","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tibs.2006.06.009_bib37","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease","volume":"47","author":"Ciarmiello","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tibs.2006.06.009_bib38","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/01.wnl.0000176071.08694.cc","article-title":"Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease","volume":"65","author":"van Oostrom","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.tibs.2006.06.009_bib39","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","article-title":"Regional cortical thinning in preclinical Huntington disease and its relationship to cognition","volume":"65","author":"Rosas","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.tibs.2006.06.009_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pscychresns.2005.05.011","article-title":"Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study","volume":"140","author":"Reading","year":"2005","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.tibs.2006.06.009_bib41","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jnnp.2004.047993","article-title":"Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study","volume":"76","author":"Kipps","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tibs.2006.06.009_bib42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ana.20121","article-title":"Functional brain changes in presymptomatic Huntington's disease","volume":"55","author":"Reading","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tibs.2006.06.009_bib43","first-page":"1715","article-title":"fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease","volume":"25","author":"Paulsen","year":"2004","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.tibs.2006.06.009_bib44","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/j.visres.2004.06.006","article-title":"Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease","volume":"44","author":"Blekher","year":"2004","journal-title":"Vision Res."},{"key":"10.1016\/j.tibs.2006.06.009_bib45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","article-title":"Onset and rate of striatal atrophy in preclinical Huntington disease","volume":"63","author":"Aylward","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tibs.2006.06.009_bib46","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.0504921102","article-title":"Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease","volume":"102","author":"Borovecki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibs.2006.06.009_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.20207","article-title":"Generalized brain and skin proteasome inhibition in Huntington's disease","volume":"56","author":"Seo","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tibs.2006.06.009_bib48","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1096\/fj.03-0079fje","article-title":"Aberrant A2A receptor function in peripheral blood cells in Huntington's disease","volume":"17","author":"Varani","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.tibs.2006.06.009_bib49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.mad.2005.09.010","article-title":"Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation","volume":"127","author":"Squitieri","year":"2006","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.tibs.2006.06.009_bib50","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mds.20373","article-title":"Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease","volume":"20","author":"Saft","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tibs.2006.06.009_bib51","first-page":"293","article-title":"Assessment of in vitro and in vivo mitochondrial function in Friedreich's ataxia and Huntington's disease","volume":"277","author":"Schapira","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tibs.2006.06.009_bib52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-005-3454-9","article-title":"Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals","volume":"269","author":"Panov","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tibs.2006.06.009_bib53","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism","volume":"14","author":"Seong","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tibs.2006.06.009_bib54","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tibs.2006.06.009_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ng1095-115","article-title":"HEAT repeats in the Huntington's disease protein","volume":"11","author":"Andrade","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tibs.2006.06.009_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2202-3-15","article-title":"The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB\/Rel\/dorsal family transcription factor","volume":"3","author":"Takano","year":"2002","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.tibs.2006.06.009_bib57","doi-asserted-by":"crossref","first-page":"15916","DOI":"10.1074\/jbc.M511007200","article-title":"Expression and characterization of full-length human huntingtin-an elongated heat repeat protein","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibs.2006.06.009_bib58","doi-asserted-by":"crossref","first-page":"36464","DOI":"10.1074\/jbc.M503672200","article-title":"Huntingtin associates with acidic phospholipids at the plasma membrane","volume":"280","author":"Kegel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibs.2006.06.009_bib59","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2004.09.016","article-title":"A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease","volume":"15","author":"Goehler","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tibs.2006.06.009_bib60","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/hmg\/ddi477","article-title":"Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral\/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro","volume":"15","author":"Clabough","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tibs.2006.06.009_bib61","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/00006982-200512001-00025","article-title":"Screening existing drugs for neurodegeneration: the National Institute of Neurologic Disorders and Stroke (NINDS) model","volume":"25","author":"Heemskerk","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.tibs.2006.06.009_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-6-1","article-title":"Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation","volume":"6","author":"Wang","year":"2005","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.tibs.2006.06.009_bib63","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbrc.2005.02.024","article-title":"Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference","volume":"329","author":"Chen","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tibs.2006.06.009_bib64","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bbrc.2005.10.061","article-title":"siRNA-mediated inhibition of endogenous Huntington disease gene expression induces an aberrant configuration of the ER network in vitro","volume":"338","author":"Omi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tibs.2006.06.009_bib65","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ymthe.2005.04.003","article-title":"Intrabody applications in neurological disorders: progress and future prospects","volume":"12","author":"Miller","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibs.2006.06.009_bib66","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibs.2006.06.009_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10048-005-0023-z","article-title":"The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease","volume":"7","author":"Metzger","year":"2006","journal-title":"Neurogenetics"},{"key":"10.1016\/j.tibs.2006.06.009_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(02)00231-8","article-title":"Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease","volume":"328","author":"Naze","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tibs.2006.06.009_bib69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0304-3940(03)00436-1","article-title":"Modulation of age at onset in Huntington's disease and spinocerebellar ataxia type 2 patients originated from eastern India","volume":"345","author":"Chattopadhyay","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tibs.2006.06.009_bib70","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.53.6.1330","article-title":"Evidence for the GluR6 gene associated with younger onset age of Huntington's disease","volume":"53","author":"MacDonald","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.tibs.2006.06.009_bib71","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1073\/pnas.94.8.3872","article-title":"Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease","volume":"94","author":"Rubinsztein","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibs.2006.06.009_bib72","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/ddg056","article-title":"Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum","volume":"12","author":"Wheeler","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tibs.2006.06.009_bib73","doi-asserted-by":"crossref","unstructured":"Gomes-Pereira, M. and Monckton, D.G. (2006) Chemical modifiers of unstable expanded simple sequence repeats: What goes up, could come down. Mutat. Res. (Feb), 23","DOI":"10.1016\/j.mrfmmm.2006.01.011"},{"key":"10.1016\/j.tibs.2006.06.009_bib74","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/378133","article-title":"A genome scan for modifiers of age at onset in Huntington disease: the HD MAPS study","volume":"73","author":"Li","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tibs.2006.06.009_bib75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/nbdi.1994.0019","article-title":"Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains","volume":"1","author":"Persichetti","year":"1994","journal-title":"Neurobiol. Dis."}],"container-title":["Trends in Biochemical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096800040600171X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096800040600171X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T19:50:36Z","timestamp":1555703436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096800040600171X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S096800040600171X"],"URL":"https:\/\/doi.org\/10.1016\/j.tibs.2006.06.009","relation":{},"ISSN":["0968-0004"],"issn-type":[{"value":"0968-0004","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}